Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India.

Intas's success and sustained growth has been driven by significant investment in all aspects of the pharmaceutical value chain over three decades. Today, Intas is one of the largest pharmaceutical organizations in India with overall 35% CAGR growth over the last 4 years and is ranked as the 12th largest pharmaceutical company in the domestic market. (As per IMS Health India, Secondary Stockist Audit (SSA), April 2011).

Intas's global strategy includes alliances with leading Global Pharmaceutical Companies for development and distribution of products as well as own product distribution.

Intas has made strategic investments in ten manufacturing facilities, globally. Between them, these facilities have received approvals from various prominent international regulatory bodies, including U.S. Food and Drug Administration (FDA), European Medicines Association (EMA), Brazilian Agência Nacional de Vigilância Sanitária (ANVISA), Australian Therapeutic Goods Association (TGA), South African Medicines Control Council (MCC) and Gulf Central Committee for Drug Registration (GCC-DR).